Research

Clinical trials

Harmonized multinational trials running across the MELLOW Consortium network, from early recruitment through completed studies.

Evaluating whether early metformin intervention slows metabolic ageing markers in pre-diabetic adults aged 50-70.

Phase II study of combination senolytic therapy in adults with early markers of frailty and elevated cellular senescence burden.

Evaluating topical NAD+ precursor formulations against placebo on validated biomarkers of skin ageing over 16 weeks.